Sarepta Therapeutics
Country
USA
Краткое название
Sarepta Therapeutics
Headquarters
245 First Street Suite 1800
Members of the board
Chris Garabedian — President and Chief Executive Officer
Jayant Aphale, PhD — Senior Vice President of Technical Operations
Ed Kaye, MD — Senior Vice President, Chief Medical Officer
Sandy Mahatme — Senior Vice President, Chief Financial Officer
Categories medicine
Infectious diseases, Orthopedics
Stage of the project
Production
Disease
Myositis, Influenza
Ticker
SRPT
Current owners
William Goolsbee — Chairman
M. Kathleen Behrens, PhD
Anthony Chase
Christopher Garabedian
John Hodgman
Gil Price, MD
Dr. Hans Wigzell, MD, PhD
Assets
1.3300
Technology
Devices, Technologies, Pharmaceuticals, Chemistry